|
| dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
| AR2_0198 | ED148952 | General Research Use | No | Female | White | 76 | 9 - AREDS AMD Severity Scale Step 7 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0516 | ED149363 | General Research Use | No | Male | White | 77 | 9 - AREDS AMD Severity Scale Step 8 | 10 - Central GA |
| AR2_0587 | ED148716 | General Research Use | No | Female | White | 83 | 9 - AREDS AMD Severity Scale Step 6 | 9 - AREDS AMD Severity Scale Step 9 |
| AR2_1459 | ED148469 | General Research Use | No | Female | White | 79 | 9 - AREDS AMD Severity Scale Step 9 | 10 - Central GA |
| AR2_1649 | ED149054 | General Research Use | No | Female | White | 79 | 9 - AREDS AMD Severity Scale Step 9 | 10 - Central GA |
| AR2_1867 | ED148911 | General Research Use | No | Male | White | 71 | 9 - AREDS AMD Severity Scale Step 9 | 10 - Central GA |
| AR2_2373 | ED149766 | General Research Use | No | Male | Other | 80 | 9 - AREDS AMD Severity Scale Step 9 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_2385 | ED149786 | General Research Use | No | Male | White | 85 | 9 - AREDS AMD Severity Scale Step 9 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_2457 | ED148390 | General Research Use | No | Female | White | 83 | 9 - AREDS AMD Severity Scale Step 9 | 9 - AREDS AMD Severity Scale Step 9 |
| AR2_2752 | ED149155 | General Research Use | No | Male | White | 67 | 9 - AREDS AMD Severity Scale Step 9 | 10 - Central GA |
| AR2_2899 | ED149069 | General Research Use | No | Female | White | 66 | 9 - AREDS AMD Severity Scale Step 9 | 10 - Central GA |
| AR2_2980 | ED149540 | General Research Use | No | Male | White | 76 | 9 - AREDS AMD Severity Scale Step 8 | 9 - AREDS AMD Severity Scale Step 9 |
| AR2_3067 | ED149289 | General Research Use | No | Male | White | 71 | 9 - AREDS AMD Severity Scale Step 8 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_3347 | ED148556 | General Research Use | No | Male | White | 77 | 9 - AREDS AMD Severity Scale Step 9 | 10 - Central GA |
| AR2_3367 | ED148924 | General Research Use | No | Female | White | 63 | 9 - AREDS AMD Severity Scale Step 8 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_3717 | ED148079 | General Research Use | No | Female | White | 68 | 9 - AREDS AMD Severity Scale Step 7 | 9 - AREDS AMD Severity Scale Step 9 |
| AR2_3939 | ED149946 | General Research Use | No | Female | White | 71 | 9 - AREDS AMD Severity Scale Step 8 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_4001 | ED149154 | General Research Use | No | Female | White | 61 | 9 - AREDS AMD Severity Scale Step 9 | 10 - Central GA |
| AR2_0309 | ED148361 | General Research Use | No | Female | White | 79 | 9 - AREDS AMD Severity Scale Step 9 | 9 - AREDS AMD Severity Scale Step 9 |
| AR2_0350 | ED148945 | General Research Use | No | Female | White | 77 | 9 - AREDS AMD Severity Scale Step 9 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |